Medical Properties Trust, Inc. (MPW) financial statements (2020 and earlier)
Company profile
| Business Address |
1000 UBRAN CENTER DRIVE BIRMINGHAM, AL 35242 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| SIC | 6798 - Real Estate Investment Trusts (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in millions)
| 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 1,462 | 821 | 171 | 83 | 196 | 145 | 46 | ||
| Cash and cash equivalents | 1,462 | 821 | 171 | 83 | 196 | 145 | 46 | ||
| Total current assets: | 1,462 | 821 | 171 | 83 | 196 | 145 | 46 | ||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 7,481 | 4,865 | 5,354 | 4,022 | 3,041 | 2,064 | 1,775 | ||
| Long-term investments and receivables | 927 | 520 | 288 | 177 | 129 | ||||
| Long-term investments | 927 | 520 | 288 | 177 | 129 | ||||
| Intangible assets, net (including goodwill) | (557) | (353) | ✕ | ||||||
| Intangible assets, net (excluding goodwill) | (557) | (353) | |||||||
| Total noncurrent assets: | 7,851 | 5,033 | 5,643 | 4,199 | 3,170 | 2,064 | 1,775 | ||
| Other undisclosed assets | 5,154 | 2,990 | 3,206 | 2,136 | 2,244 | 1,539 | 1,084 | ||
| TOTAL ASSETS: | 14,467 | 8,844 | 9,020 | 6,419 | 5,609 | 3,747 | 2,905 | ||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Noncurrent Liabilities | |||||||||
| Other undisclosed liabilities | 7,439 | 4,283 | 5,185 | 3,165 | 3,502 | 2,365 | 1,560 | ||
| Total liabilities: | 7,439 | 4,283 | 5,185 | 3,165 | 3,502 | 2,365 | 1,560 | ||
| Stockholders' equity | |||||||||
| Stockholders' equity attributable to parent | 7,028 | 4,547 | 3,821 | 3,248 | 2,102 | 1,382 | 1,344 | ||
| Common stock | 1 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Treasury stock, value | (1) | (1) | (1) | (0) | (0) | (0) | (0) | ||
| Additional paid in capital | 7,008 | 4,443 | 4,333 | 3,775 | 2,594 | 1,765 | 1,618 | ||
| Accumulated other comprehensive loss | (63) | (58) | (26) | (93) | (73) | (22) | (9) | ||
| Retained earnings (accumulated deficit) | 83 | 163 | (486) | (434) | (419) | (361) | (265) | ||
| Stockholders' equity attributable to noncontrolling interest | 0 | 14 | 15 | 5 | 5 | ||||
| Total stockholders' equity: | 7,028 | 4,561 | 3,835 | 3,253 | 2,107 | 1,382 | 1,344 | ||
| TOTAL LIABILITIES AND EQUITY: | 14,467 | 8,844 | 9,020 | 6,419 | 5,609 | 3,747 | 2,905 | ||
Income statement (P&L) ($ in millions)
| 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 854 | 785 | 705 | 541 | 442 | 313 | 243 | |
| Net investment income | 162 | 129 | 108 | 112 | 63 | |||
| Cost of revenue | (262) | (233) | (35) | (64) | (4) | (25) | (44) | |
| Cost of goods and services sold | (168) | (84) | (6) | (56) | (4) | (25) | (44) | |
| Gross profit: | 592 | 551 | 669 | 477 | 438 | 288 | 198 | |
| Operating expenses | (249) | (213) | (184) | (136) | (175) | (168) | (88) | |
| Other undisclosed operating income | 23 | 43 | ||||||
| Operating income: | 344 | 338 | 486 | 342 | 263 | 143 | 154 | |
| Nonoperating income (expense) | 30 | 681 | (194) | (116) | (123) | (92) | (64) | |
| Profit from real estate operations | 13 | |||||||
| Interest and debt expense | (238) | (223) | (177) | (160) | (121) | (98) | (67) | |
| Income (loss) from continuing operations before equity method investments, income taxes: | 136 | 796 | 114 | 66 | 19 | (47) | 23 | |
| Other undisclosed income from continuing operations before income taxes | 238 | 223 | 180 | 153 | 122 | 98 | ||
| Income from continuing operations before income taxes: | 374 | 1,019 | 294 | 219 | 141 | 51 | 23 | |
| Income tax expense (benefit) | 3 | (1) | (3) | 7 | (2) | (0) | (1) | |
| Other undisclosed income from continuing operations | 67 | |||||||
| Income from continuing operations: | 376 | 1,018 | 291 | 226 | 140 | 51 | 89 | |
| Income (loss) from discontinued operations | (0) | (0) | 8 | |||||
| Net income: | 376 | 1,018 | 291 | 226 | 140 | 51 | 97 | |
| Net loss attributable to noncontrolling interest | (2) | (2) | (1) | (1) | (0) | (0) | (0) | |
| Net income available to common stockholders, diluted: | 375 | 1,017 | 290 | 225 | 140 | 51 | 97 | |
Comprehensive Income ($ in millions)
| 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | ||
|---|---|---|---|---|---|---|---|---|
| Net income: | 376 | 1,018 | 291 | 226 | 140 | 51 | 97 | |
| Other undisclosed comprehensive income (loss) | (5) | (32) | 67 | (20) | (51) | (13) | 4 | |
| Comprehensive income: | 372 | 986 | 358 | 206 | 89 | 38 | 101 | |
| Comprehensive income (loss), net of tax, attributable to noncontrolling interest | (2) | (2) | (1) | (1) | (0) | (0) | 0 | |
| Other undisclosed comprehensive loss, net of tax, attributable to parent | (0) | |||||||
| Comprehensive income, net of tax, attributable to parent: | 370 | 985 | 357 | 205 | 89 | 38 | 101 | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.